According to CoinMeta, DeepSeek aims to raise approximately 100 billion yuan in its latest round of financing. Analysts say that the continuous advancement of its model capabilities is expected to drive the prosperity of the AI application ecosystem. The company has developed an integrated AIoT solution that combines "modules + AI Agent + AI algorithms". In addition, Zhiyuan has open-sourced its first real-scenario physical agent dataset. Institutions believe that AI large models continue to bring vitality to robots, and there is a broad market space in the future. The company is making arrangements for multiple sensors such as olfaction, touch, balance, force control, and vision for the embodied intelligence industry, providing more comprehensive perception solutions. Currently, DeepSeek also has one innovative drug project under development, which is in the IB / II phase of clinical trials.